SCHEMBL18854855

SCHEMBL18854855

CC1(C)c2ccccc2-c2c1c1ccccc1n2-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ ATM Q13315 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ACP1 P24666 4/20 0.33
▸ PDE5A O76074 3/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17705437 0.90 IL1R1 (0.36) L3MBTL1ATMKDM4EALDH1A1TP53
SCHEMBL20998112 0.88 PDE10A (0.35) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL18927499 0.86 ALDH1A1 (0.46) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL15860848 0.85 L3MBTL1 (0.35) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL15860744 0.85 L3MBTL1 (0.34) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL31840 0.84 L3MBTL1 (0.31) L3MBTL1ATMKDM4EALDH1A1TP53
SCHEMBL15860703 0.84 IL1R1 (0.34) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL17705438 0.83 KMT2A (0.38) L3MBTL1KDM4EALDH1A1MAPTHPGD
SCHEMBL17367764 0.83 PTGER4 (0.33) MAPK1HSD17B10PDE10AABCG2
SCHEMBL15860667 0.83 MAPK1 (0.31) L3MBTL1ATMKDM4EMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563181-B2 Amine compounds for organic light-emitting diode and organic light-emitting diode including the same SFC CO., LTD. (KR) 2023-01-24 — — US disclosed
US-20170141322-A1 NOVEL AMINE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SFC CO., LTD. (KR) 2017-05-18 — — US disclosed
US-20170141322-A1 NOVEL AMINE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SFC CO., LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141322-A1 NOVEL AMINE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME DRD1, DRD4, DRD2 L3MBTL1 149/4885ATM 661/4885KDM4E 919/4885
US-11563181-B2 Amine compounds for organic light-emitting diode and organic light-emitting diode including the same DRD1, DRD4, DRD2 L3MBTL1 133/4885ATM 558/4885KDM4E 1098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback